Monitoring and management of cardiometabolic risk factors in schizophrenia- A global perspective: rationale, aims and methods
Year: 2014
Type: article
Study design: Study Protocol
Abstract: Backgrouund; The excess morbidity and mortality associated with schizophrenia is partly due to cardiovascular diseases resulting from the complex inter-relationships between unhealthy life style including, metabolic problems, and the metabolic risks associated with the use of psychotropic medications. The current project involves patients with schizophrenia, their informal care providers and the health professionals, who treat them. Aims; Our primary aim in the Monitoring and Management of Cardiovascular Risk factors In Schizophrenia (MOMACRIS) Project is to determine whether an integrated mental and physical health care approach that involves patients with schizophrenia, their informal care providers and the health professionals who treat them, would improve identification, management and outcome of cardio-metabolic risk factors in these patients. Methods; We assess the knowledge and attitude of patients, their informal care providers and health care professionals about general cardiometabolic risk factors and life style modification. We also assess the current cardiometabolic monitoring and management practices by the health care professionals who treat patients with schizophrenia and we identify any barriers that may be limiting what theses care professionals do. At baseline we assess the needs for improved cardiometbolic monitoring. Thereafter we carry on culturally-tailored psycho-educational based interventions directed at the patients with schizophrenia, their informal care providers and health care professionals following the baseline assessments of the identified needs for improved cardiometbolic monitoring. This will be achieved in an integrated collaborative effort between psychiatrists, psychologists, general/family physicians (or internists/endocrinologists), dieticians and physiotherapists. Conclusion; Morbidity and mortality from cardiometabolic risk in schizophrenia is higher than chance occurrence. Identification and management of these risk factors seem to be hampered by a number of barriers despite years of developing one guide line after another. There is need to re-evaluate the current knowledge, beliefs and practice of everyone concerned with schizophrenia.
Authors: Uwakwe Richard, Padmavati Ramachandran, Marc D. Binder, Mehrul Hasnain, Davy Vancampfort, Omoaregba Joyce, Peter Hjorth, Modebe Ifeoma, Haider Muhammad Imran, Ogualili Placidus, Haddad Peter, Jorgensen Povl, Reinhold Kilian, Becker Thomas, Lahore Pakistan, Ludwig Heilmeyer-Str, Günzburg Deutschland, Richard Uwakwe, Padmavati Ramachandran, Damjana Marc, Peter Hjorth, Haider Muhammad Imran, Jorgensen Povl
Institutions: University of Southern Denmark, Aarhus University Hospital
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W124624564